arrow
M

Martin Stuschke

University Medicine Essen
H指数:61
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Machine learning models for adverse drug reaction prediction. A systematic review and three-level multilevel meta-analysis

机器学习模型用于药物不良反应预测:系统综述和三级多层元分析

2026-09-150
OA
A multicenter analysis of prognostic factors for patients undergoing re-irradiation for recurrent glioblastoma

多中心分析复发性胶质母细胞瘤再放疗患者的预后因素

2026-09-020
OAAI
Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation

松果体区乳头状肿瘤中的年龄相关表观基因组异质性:一项多中心YoungNOA研究

2026-08-280
OA
Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315)

不可切除III期非小细胞肺癌患者行根治性放化疗后的度鲁特单抗巩固治疗:来自德国前瞻性、观察性CRISP登记研究(AIO-TRK-0315)的真实世界队列分析

Cancers
IF4.4
2026-08-170
OAAI
Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF)

新诊断胶质母细胞瘤中肿瘤治疗电场在放疗前和放疗期间的安全性与可行性:PriCoTTF I/II期试验中Arm A可行性队列的结果

2026-07-270
OAAI
PROGNOSTIC VALUE OF PSMA PET IN METACHRONOUS OLIGOMETASTATIC PROSTATE CANCER

前列腺特异性膜抗原PET在异时性寡转移性前列腺癌中的预后价值

2026-05-010
PRE
FDG-PET/CT based small volume accelerated immuno chemoradiotherapy in locally advanced NSCLC (PACCELIO) – a randomized, open-label, multicenter phase II trial protocol

基于FDG-PET/CT的小体积加速免疫放化疗在局部晚期NSCLC中的应用(PACCELIO)——一项随机、开放标签、多中心II期临床试验方案

2026-04-170
OAAI
Phosphorylated mTOR immunohistochemistry–guided use of temsirolimus in recurrent IDH-wildtype glioblastoma: a real-world retrospective series

磷酸化mTOR免疫组化指导下的替西罗莫司在复发性IDH野生型胶质母细胞瘤中的应用:一项真实世界回顾性系列研究

2026-04-070
OAAI
Radiation Dose-Dependent and -Independent Pulmonary Infiltrates in Patients with High-Grade Pneumonitis After Radiochemotherapy and Durvalumab Consolidation for Stage III NSCLC

放疗剂量依赖性和非依赖性肺浸润:III期非小细胞肺癌患者在放化疗及度伐利尤单抗巩固治疗后发生重度肺炎的研究

2026-03-110
OAAI
Homologous Recombination and Alternative End-Joining Repair Pathways are Important Determinants of Radiosensitivity to Proton Radiotherapy

同源重组和替代末端连接修复通路是质子放射治疗放射敏感性的重要决定因素

2026-02-260
OAAI
A tumor DNA-Methylome derived signature of Hypoxia Identifies HPV-negative head and neck cancer patients at risk for distant metastasis after postoperative radiochemotherapy (PORT-C)

肿瘤DNA甲基组衍生缺氧特征可识别接受术后放化疗(PORT-C)后存在远处转移风险的HPV阴性头颈癌患者

2026-02-090
OAAI